4 days agoCMS Chronic-Care Technology Efforts Signal Reimbursement and Market Shifts
CMS activity involving chronic-care technology pilots and reimbursement, alongside advocacy on wearable-device rules and remote-care connectivity, points to an evolving health technology market. The reported lobbying activity may influence policy, but the article identifies no solicitation, award, contract value, or defined purchasing requirement.
6 days agoFDA Finalizes Guidance for Prescription-Drug Companion Apps
The FDA finalized recommendations for how prescription-drug companion apps should handle promotional content, FDA-required labeling, prescribing-information references, and agency submissions. The guidance may inform product reviews and vendor discussions, but it announces no funding, solicitation, contract, or mandatory procurement requirement.
95 days agoFDA Initiates TEMPO Pilot with Dexcom for Digital Health Devices
The FDA has chosen Dexcom, Inc. as the first participant in its TEMPO pilot, aiming to improve chronic disease management under Medicare. This selection opens new procurement avenues for contractors focused on digital health technologies and data analytics that support innovative healthcare delivery.